We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+1.1%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$811M
AUM Growth
-$7.13M
Cap. Flow
-$9.26M
Cap. Flow %
-1.14%
Top 10 Hldgs %
36.68%
Holding
195
New
20
Increased
28
Reduced
44
Closed
14

Top Buys

Rank Stock Value
1
RHT
Red Hat Inc
RHT
+$2.38M
2
CI icon
Cigna
CI
+$1.7M
3
CVLT icon
Commault Systems
CVLT
+$1.63M
4
AMBA icon
Ambarella
AMBA
+$1.39M
5
NXPI icon
NXP Semiconductors
NXPI
+$1.2M

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$2.48M
2
AMZN icon
Amazon
AMZN
+$1.65M
3
MCK icon
McKesson
MCK
+$1.56M
4
BSX icon
Boston Scientific
BSX
+$1.55M
5
LLTC
Linear Technology Corp
LLTC
+$1.37M

Sector Composition

Rank Sector Weight
1 Technology 35.81%
2 Financials 22.64%
3 Healthcare 16.6%
4 Communication Services 7.34%
5 Energy 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VC icon
76
Visteon
VC
$2.77B
$2.28M 0.28%
23,405
– –
NVS icon
77
Novartis
NVS
$295B
$2.22M 0.27%
26,338
– –
WAT icon
78
Waters Corp
WAT
$36.8B
$2.2M 0.27%
22,200
+1,200
+6% +$124K
MCK icon
79
McKesson
MCK
$98.5B
$2.19M 0.27%
11,250
-8,100
-42% -$1.56M
ACH
80
Accendra Health
ACH
$240M
$2.12M 0.26%
64,600
– –
IPG
81
DELISTED
Interpublic Group of Companies
IPG
$2.07M 0.26%
113,100
– –
RDS.A
82
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.04M 0.25%
26,795
+120
+0.4% +$9.63K
LLY icon
83
Eli Lilly
LLY
$1.07T
$2.04M 0.25%
31,400
– –
PAYX icon
84
Paychex
PAYX
$40.4B
$2M 0.25%
45,229
+80
+0.2% +$3.36K
WOOF
85
DELISTED
VCA Inc.
WOOF
$1.99M 0.24%
50,500
– –
COV
86
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$1.98M 0.24%
22,900
– –
UIS icon
87
Unisys
UIS
$227M
$1.98M 0.24%
84,400
– –
CRUS icon
88
Cirrus Logic
CRUS
$6.74B
$1.94M 0.24%
93,050
+4,100
+5% +$95K
SNY icon
89
Sanofi
SNY
$104B
$1.87M 0.23%
33,200
– –
AMBA icon
90
Ambarella
AMBA
$2.99B
$1.84M 0.23%
+42,075
New +$1.39M
GSBC icon
91
Great Southern Bancorp
GSBC
$863M
$1.78M 0.22%
58,720
– –
GSK icon
92
GSK
GSK
$103B
$1.74M 0.21%
30,240
– –
PMC
93
DELISTED
PharMerica Corporation
PMC
$1.69M 0.21%
69,242
– –
ZBH icon
94
Zimmer Biomet
ZBH
$17.7B
$1.68M 0.21%
17,201
– –
CI icon
95
Cigna
CI
$76.6B
$1.65M 0.2%
+18,200
New +$1.7M
CVLT icon
96
Commault Systems
CVLT
$5.89B
$1.59M 0.2%
+31,650
New +$1.63M
PDCO
97
DELISTED
Patterson Companies, Inc.
PDCO
$1.59M 0.2%
38,400
– –
CRL icon
98
Charles River Laboratories
CRL
$10.9B
$1.57M 0.19%
26,300
+2,800
+12% +$160K
ILMN icon
99
Illumina
ILMN
$29.4B
$1.53M 0.19%
9,602
– –
CSGS
100
DELISTED
CSG Systems International
CSGS
$1.52M 0.19%
57,919
-2,380
-4% -$64.4K
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q3 2014 Portfolio in Review

As of Q3 2014, Oak Associates held 195 positions worth $811M, down 0.87% from $819M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Oak Associates's Q3 2014 filing shows 20 new, 28 increased, 44 reduced and 14 closed positions. Its largest new stake was Red Hat Inc: 40,875 shares worth $2.29M. The largest sale was KLA, an estimated $2.48M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • Oak Associates's largest Q3 2014 buy was Red Hat Inc: 40,875 shares worth $2.29M.
  • Oak Associates added most to Quest Diagnostics in Q3 2014, an estimated $1.12M increase.
  • Oak Associates's biggest Q3 2014 reduction was KLA, cutting an estimated $2.48M.
  • Oak Associates fully exited Boston Scientific in Q3 2014, selling an estimated $1.55M.
  • Oak Associates's ten largest holdings make up 37% of its $811M portfolio in Q3 2014.
  • Oak Associates opened 20 new positions and closed 14 in Q3 2014.
  • Oak Associates's portfolio value fell 0.87% quarter-over-quarter to $811M.

Based on Oak Associates's 13F filing for Q3 2014, filed 16 Dec 2014.